Loading...
RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Food and Drug Administration

Sort By: Relevancy | Date | Type
Displaying items 109-120 of 1662
» View wsbt.com items only
    May 9, 2013 |Story| South Florida Sun-Sentinel
  1. PowerMedica owner finally going to prison, gets break for helping feds convict his dad

    The former operator of a Deerfield Beach drug company that illegally sold human growth hormones and anabolic steroids got a significant break on his prison sentence this week because he helped convict other criminals – including his father....

    Tags: Justice System, Punishment, Deerfield Beach, Steroids, Prosecution

  2. May 13, 2013 |Story| Reuters
  3. Suplementos sexuales herbáceos a menudo contienen ingredientes del Viagra

    Reuters
    Por Kerry Grens 13 may (Reuters) - Un estudio revela que, a menudo, los suplementos herbáceos para mejorar la sexualidad masculina contienen ingredientes activos de los fármacos para la disfunción eréctil como el Viagra. Además, algunos de esos...

    Tags: Cialis (drug), Pfizer Inc., Viagra (drug), Corporate Officers

  4. May 9, 2013 |Story| Hartford Courant
  5. LETTER: Good Reasons For Genetic Labeling

    I strongly support labeling of genetically engineered food. As a pediatric hematologist/oncologist, I was a loyal supporter of mainstream pediatrics during my professional years but have learned otherwise in retirement. Much animal data shows the...

    Tags: Science and Technology, Arable Farming, Vaccines, Genetic Engineering, Health Organizations

  6. May 13, 2013 |Story| AP Broadcast
  7. Elan enters $1 billion royalty deal with Theravance over potential respiratory drug sales

    Irish drugmaker Elan Corp. PLC plans to pay $1 billion for the right to future royalties from four respiratory treatments being developed by Theravance Inc. and GlaxoSmithKline. The deal announced Monday will give Elan 21 percent of the future...

    Tags: Elan Corporation Plc, Theravance Incorporated, GlaxoSmithKline PLC, Health Organizations, Moody's Corporation

  8. May 9, 2013 |Story| Los Angeles Times
  9. Wrigley holds off on caffeinated gum as FDA reviews caffeine

    Less than a week after the Food and Drug Administration announced that it would investigate the safety of added caffeine in U.S. food and beverage products, Wrigley North America has decided to put its bid to market a caffeinated gum on hold out of...

    Tags: Energy Drinks, Food Industry, Taurine (dietary supplement), Consumer Goods Industries, Agriculture

  10. May 13, 2013 |Story| Reuters
  11. Ranbaxy pleads guilty, to pay $500 million in U.S. settlement

    Reuters
    (Reuters) - Indian generic drugmaker Ranbaxy Laboratories Ltd pleaded guilty on Monday to felony charges related to drug safety and will pay $500 million in civil and criminal fines under the settlement agreement with the U.S. Department of Justice....

    Tags: Justice System, National Government, Statins (drugs), Lipitor (drug), Government

  12. May 13, 2013 |Story| Reuters
  13. Elan's $1 billion drug royalty deal aids bid defense

    Reuters
    DUBLIN (Reuters) - Irish drugmaker Elan Corporation has agreed a $1 billion royalties deal that could soothe concerns about its potentially risky acquisition strategy and fend off a takeover bid from Royalty Pharma. Elan, battling to keep its...

    Tags: Elan Corporation Plc, Theravance Incorporated, Shareholders, Companies and Corporations, Asthma

  14. May 12, 2013 |Story| Los Angeles Times
  15. Bill would regulate 'biosimilar' drugs

    SACRAMENTO — Two of the nation's largest biotech companies — Amgen Inc. of Thousand Oaks and Genentech Inc. of South San Francisco — are fighting in Sacramento to keep a tight grip on some of their most lucrative drugs.
    SACRAMENTO — Two of the nation's largest biotech companies — Amgen Inc. of Thousand Oaks and Genentech Inc. of South San Francisco — are fighting in Sacramento to keep a tight grip on some of their most lucrative drugs. At stake is a...

    Tags: Health and Medical Professionals, U.S. Senate Committee on Appropriations, Jerry Hill, Amgen Inc., Imports

  16. May 12, 2013 |Story| Reuters
  17. UPDATE 1-Elan strikes $1 bln royalty deal with Theravance

    Reuters
    * Elan to acquire newly approved Breo as part of $1 bln deal * Irish drugmaker to announce further deals in due course * Looks to outmanoeuvre Royalty with second shareholder dividend By Padraic Halpin DUBLIN, May 13 (Reuters) - Elan stepped up its...

    Tags: Thomson Corporation, Theravance Incorporated, Elan Corporation Plc, GlaxoSmithKline PLC, Asthma

  18. May 10, 2013 |Story| Los Angeles Times
  19. FDA allows sales of generic Opana painkiller to continue

    Federal regulators said Friday that they would continue to allow sales of generic Opana, a narcotic painkiller similar to OxyContin, even though the pills are prone to abuse. Like OxyContin, Opana is an extended-release narcotic designed to offer pain...

    Tags: Pain, OxyContin (drug), Prescription Drugs, Los Angeles County Sheriff's Department, Drugs and Medicines

  20. May 11, 2013 |Story| Los Angeles Times
  21. Judge again rejects limits on emergency contraception

    In yet another scathing critique of government health officials, a federal judge refused Friday to stay his order making emergency contraceptives available to consumers of all ages without a prescription.
    In yet another scathing critique of government health officials, a federal judge refused Friday to stay his order making emergency contraceptives available to consumers of all ages without a prescription. Calling government efforts to restrict the...

    Tags: Justice System, National Government, Birth Control, Government, Family Planning

  22. May 11, 2013 |Story| Los Angeles Times
  23. Generic version of narcotic Opana still for sale despite concerns

    Federal regulators said Friday they would continue to allow sales of generic Opana, a narcotic painkiller similar to OxyContin, even though the pills are prone to abuse. Like OxyContin, Opana is an extended-release narcotic designed to offer pain...

    Tags: Pain, OxyContin (drug), Prescription Drugs, Drugs and Medicines

< Previous1 2 3 4 5 6 7 8 9  10  11-139Next >
Original site for Food and Drug Administration topic gallery.